Untitled Document Today's Rundown Nektar’s long-acting IL-2 NKTR-214 has 'zero value,' claims analyst James Allison, Tasuku Honjo win Nobel for CTLA-4/PD-1 discoveries Forbion closes fourth EU-focused biotech fund at €360M Novartis-backed cell therapy startup Gamida files for IPO Dragonfly Therapeutics in $695M cancer R&D pact with Merck Featured Story | | | Monday, October 1, 2018 Nektar Therapeutics is a multibillion-dollar biotech with most of its value tied to a single drug—and that drug simply doesn’t work, according to a just-published report. |
|
|
| This week's sponsor is the Fierce Innovation Awards – Life Sciences Edition. | | | |
Top Stories Monday, October 1, 2018 James Allison and Tasuku Honjo have jointly received the Nobel Prize in physiology or medicine for their work on immune checkpoints. Allison and Honjo set the stage in the 1990s for the current immuno-oncology boom by discovering the cancer-killing potential of CTLA-4 and PD-1, respectively. Monday, October 1, 2018 Forbion has closed its fourth fund at €360 million ($417 million). The addition of €90 million since the first close in July means Forbion has pulled in almost twice as much money as it managed for its third fund. Monday, October 1, 2018 Gamida Cell has filed to raise $69 million in a Nasdaq IPO. The Novartis-backed cell therapy player wants the money to wrap up a phase 3 trial of its lead candidate in patients with blood cancers. Monday, October 1, 2018 More than a year after the insect-inspired biotech Dragonfly Therapeutics penned a blood cancer pact with big biotech Celgene, it's back at the deal table with a potentially meaty biobucks deal with Merck and a focus on solid tumors. | This week's sponsor is IQVIA. | | | Congratulations Fierce 15
We admire and recognize your passion to address unmet medical needs and we support your vision to advance modern medicine. You Are Driving Innovation Forward. Let's talk. |
Resources Sponsored by: RWS Life Sciences Examine the linguistic and cultural considerations of global eCOA and BYOD. Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Docusign Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin? Sponsored by: Veeva A top 20 pharma and growing biotech re-engineer regulatory processes. Sponsored by: Sciformix Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be! Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Drug Development Boot Camp® 2018 – Registration closes 30 October - Register Now! November 14-15, 2018 | Boston, MA | Registration closes on the 30 of October 2018 due to the need for participants to complete pre-Boot Camp preparations. Register now and start preparing for this intensive training in drug development. AI World Conference and Expo 2018 Monday, December 3, 2018 | 10/5/18 – Early Deadline PepTalk: The Protein Science Week January 14, 2019 | October 19, 2018 – Early Deadline
FierceBiotech 3rd Drug Development Forum October 1–3, 2018 | Hilton Boston Logan Airport Hotel | Boston, MA Compliance Certification Program at Seton Hall Law October 8-11, 2018 | Newark, NJ BioImmersion: Biotech for the Non-Scientist October 16-18, 2018 | Chicago, IL Fierce Innovation Awards: Life Sciences Edition 2018 Welcome to the inaugural Neuromuscular Drug Development Summit October 29-31, 2018 | Boston, MA, USA FierceBiotech Executive Summit: London October 30, 2018 | Royal Society of Medicine Drug Development Immersion November 1-2, 2018 | Boston, MA European Healthcare Compliance Certification Program November 5-8, 2018 | Paris, France Understanding Commercialization Within Biopharma Nov 7-8, 2018 | Boston, MA BioBasics: Biotech For The Non-Scientist December 5-6, 2018 | Boston, MA Drug Development Immersion December 5-6, 2018 | San Diego, CA Understanding Drug Pricing and Reimbursement December 12, 2018 | Boston, MA | 